Clinical Trial Update: Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating celecoxib, recombinant interferon alfa-2b, and rintatolimod in patients with colorectal cancer metastasized to the liver; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer Ajcc V7
• Colorectal Cancer with Liver Metastases
• Stage Iva Colorectal Cancer Ajcc V7
• Stage Ivb Colorectal Cancer Ajcc V7

Drugs mentioned

• Celecoxib (Celecoxib)
• Rintatolimod (rintatolimod)
• recombinant interferon alfa-2b (interferon alfa-2b)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2022-03-02